Judge Again Tosses Abbott Patent For Inequitable Conduct

Law360, New York (March 28, 2012, 5:40 PM EDT) -- A California district court on Tuesday ruled again that Abbott Laboratories’ patent covering blood glucose monitoring technology was unenforceable, finding that an Abbott attorney and a scientist committed inequitable conduct by concealing information about the patent from the U.S. Patent and Trademark Office.

U.S. District Judge William Alsup held that in filing for a patent covering blood-glucose test strips for diabetes management, attorney Lawrence Pope and Dr. Gordon Sanghera deliberately concealed information originating from the European Patent Office that would have blocked Abbott’s U.S. patent from...
To view the full article, register now.